With many sufferers unaware they’ve dry mouth, privately held Ok Prescription drugs has launched the “first ever” in-office Customized Xerostomia Protocol (PXP) device to help dentists in figuring out and managing the situation.
Moderately than providing a one-size-fits-all answer, the PXP is designed to be used with each affected person at each appointment. It gives clear pointers and an easy-to-follow technique to establish and educate sufferers on dry mouth signs. Crucially, the PXP additionally facilitates re-evaluating remedy primarily based on sufferers’ evolving well being wants.
‘Silent pandemic’
“Sarcastically, many people affected by dry mouth stay unaware of their situation,” mentioned Melissa Turner, BASDH, RDHEP, EFDA, a number one registered dental hygienist and dental model strategist. “Xerostomia has turn out to be a silent pandemic that may be detrimental to our sufferers’ systemic well being, usually diminishing their high quality of life.”
The PXP device was developed in partnership with Turner, who emphasised its function in heightening consciousness amongst dental professionals and sufferers. “The PXP seeks to propel the dialog ahead and allow us to face collectively for xerostomia reduction,” she added.
Rise in dry mouth circumstances
The protocol’s launch comes amid a documented rise in dry mouth circumstances, a situation as soon as primarily related to the aged or disease-related xerostomia. In keeping with the School of Dental Hygienists of Ontario, prevalence is at the very least 20 per cent within the basic inhabitants, with elevated prevalence in females (as much as 30 per cent) and the aged (as much as 50 per cent). In america, xerostomia impacts an estimated 30 per cent of sufferers older than 65 years and as much as 40 per cent of sufferers older than 80 years, in line with the American Dental Affiliation. Moreover, the rise can also be as a result of uncomfortable side effects of most medicines together with trending weight reduction medication, use of CPAP machines, and the rising use of marijuana.
What impressed the brand new PXP?
The discharge of the PXP follows the 2023 launch of Ok Prescription drugs’ flagship product, Aquoral Protecting Oral Spray for Dry Mouth Reduction. Aquoral, a patented lipid-based formulation, creates a protecting barrier on the oral mucosa that is still intact after consuming or ingesting, making it an efficient complement to present xerostomia therapies.
“Many have described Aquoral as a transformative product, which impressed the event of our new PXP,” mentioned Bennett Blakeman, CEO of Ok Prescription drugs. “Our mission is to make sure communities not should undergo from this preventable situation or its usually detrimental systemic results.”